Loading…
Reported covered position: Senate HELP Subcommittee staff
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
STRYKER CORPORATION via STRYKER CORPORATION
2026 · third_quarter · Q3
Issues related to global supply chains for medical devices Issues related to med tech reimbursement globally
Issues related to global supply chains Issues related to reprocessing Issues related to digital health
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Source: Senate LDA
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act H.R. 3303, the Software Act - FDA regulation of health information technology and mobile medical applications
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act H.R. 3303, the Software Act - FDA regulation of health information technology, mobile medical applications and software Telehealth legislation Energy & Commerce Committee 21st Century Cures Initiative
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act, in particular the custom device provision H.R. 3303, the Software Act - FDA regulation of health information technology and mobile medical applications
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act, HR 3303, the Software Act - FDA regulation of health information technology and mobile medical applications
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 The Medical Device access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices Legislation to make the R&D tax credit permanent
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - repeal the 2.3% excise tax on medical devices
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - repeal the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 The Medical Device access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices Legislation to make the R&D tax credit permanent
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232, Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Protect Medical Innovation Act of 2013
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Medical Device Access and Innovation Protection Act
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 232, Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Novel Device Regulatory Relief Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Guidance Accountability and Transparency Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
FDA Renewing Efficiency From Outside Reviewer Management Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Premarket Predictability Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Food and Drug Administration Mission Reform Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Keeping America Competitive Through Harmonization Act of 2011
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Health Care Cost Reduction Act of 2012
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, and H.R. 488
Health Care Cost Reduction Act of 2012
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Health Care Cost Reduction Act of 2012
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Health Care Cost Reduction Act of 2012
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, and H.R. 488
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, and H.R. 488
To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes.
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
American Middle Class Tax (AMT) Relief Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes Reform of the FDA 510(k) regulatory pathway
H.R. 1346, The Medical Device Safety Act of 2009 Reform of the 510(k) regulatory pathway
HR 1346/S 540, The Medical Device Safety Act of 2009 Comparative effectiveness research to compare the clinical effectiveness of medical treatments
HR 1346/S540, The Medical Device Safety Act of 2009 HR 2813, The National Knee and Hip Replacement Registry Act of 2009 Reform of the 510(k) regulatory pathway Statement for the record on arthritis and related procedures
National Knee and Hip Replacement Registry Act of 2009
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
HR 1346/S540, The Medical Device Safety Act of 2009 HR 2813, The National Knee and Hip Replacement Registry Act of 2009 Reform of the 510(k) regulatory pathway Statement for the record on arthritis and related procedures
America's Affordable Health Choices Act of 2009
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 301, Physician Payments Sunshine Act, legislation to require the disclosure of relationships between physicians and drug and device manufacturers S. 1679, the Affordable Health Choices Act, HR 3200, America's Affordable Health Choices Act of 2009, and America's Healthy Future Act - specifically comparative effectiveness research, physician disclosure, bundling, device registry and device tax proposals
S. 301, Physician Payments Sunshine Act, legislation to require the disclosure of relationships between physicians and drug and device manufacturers S. 1679, the Affordable Health Choices Act, HR 3200, America's Affordable Health Choices Act of 2009, and America's Healthy Future Act - specifically comparative effectiveness research, physician disclosure, bundling, device registry and device tax proposals
Physician Payments Sunshine Act of 2009
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 301, Physician Payments Sunshine Act, legislation to require the disclosure of relationships between physicians and drug and device manufacturers Comparative Effectiveness Research to compare the clinical effectiveness of medical treatments New Technology Add-on Payments related to Medicare bundling proposals included in healthcare reform
Physician Payments Sunshine Act of 2009
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 301, Physician Payments Sunshine Act, legislation to require the disclosure of relationships between physicians and drug and device manufacturers S. 1679, the Affordable Health Choices Act, HR 3200, America's Affordable Health Choices Act of 2009, and America's Healthy Future Act - specifically comparative effectiveness research, physician disclosure, bundling, device registry and device tax proposals
HR 1346/S 540, The Medical Device Safety Act of 2009 Comparative effectiveness research to compare the clinical effectiveness of medical treatments
HR 1346/S540, The Medical Device Safety Act of 2009 HR 2813, The National Knee and Hip Replacement Registry Act of 2009 Reform of the 510(k) regulatory pathway Statement for the record on arthritis and related procedures
H.R. 6381, The Medical Device Safety Act of 2008
H.R. 6381, The Medical Device Safety Act of 2008
H.R. 6381, The Medical Device Safety Act of 2008 HCR-related legislation
Physician Payments Sunshine Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 2221, the Medical Device Price Transparency Act S. 2029, the Physician Payment Sunshine Act Revisions to Physician Self-Referral Law
Physician Payments Sunshine Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 2029, the Physician Payment Sunshine Act Revisions to Physician Self-Referral Law Medicare Reimbursement Issues
Transparency in Medical Device Pricing Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 2221, the Medical Device Price Transparency Act S. 2029, the Physician Payment Sunshine Act Revisions to Physician Self-Referral Law
Pediatric Medical Device Safety and Improvement Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 1082/H.R. 2900 Reuthorization of the Medical Device User Fee and Modernization Act H.R. 1494/S.830 The Pediatric Medical Device Safety and Improvement Act
Food and Drug Administration Amendments Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 1082/H.R. 2900 Reuthorization of the Medical Device User Fee and Modernization Act H.R. 1494/S.830 The Pediatric Medical Device Safety and Improvement Act
Medicare, Medicaid, and SCHIP Extension Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 2499, the Medicare, Medicaid and SCHIP Extension Act of 2007 Medicare reimbursement
Pediatric Medical Device Safety and Improvement Act of 2007
Client: STRYKER CORPORATION · Firm: STRYKER CORPORATION
S. 1082/H.R. 2900 Reuthorization of the Medical Device User Fee and Modernization Act H.R. 1494/S.830 The Pediatric Medical Device Safety and Improvement Act
STRYKER CORPORATION via STRYKER CORPORATION
2026 · second_quarter · Q2
Medicare extenders for EMS Payment models, coverage decisions and protecting access to innovation
Issues related to global supply chains for medical devices Issues related to med tech reimbursement globally
Issues related to global supply chains Issues related to reprocessing Issues related to digital health
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2026 · first_quarter · Q1
Stroke pathways Medicare extenders for EMS Payment models, coverage decisions and protecting access to innovation
Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs Issues related to digital health Issues related to smoke evacuation in the OR
Issues related to global supply chains for medical devices Issues related to med tech reimbursement globally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
STRYKER CORPORATION via STRYKER CORPORATION
2025 · fourth_quarter · Q4
Stroke pathways Medicare extenders for EMS Payment models, coverage decisions and protecting access to innovation
Issues related to global supply chains for medical devices Issues related to med tech reimbursement globally
Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs Issues related to digital health Issues related to smoke evacuation in the OR
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
STRYKER CORPORATION via STRYKER CORPORATION
2025 · third_quarter · Q3
Issues related to global supply chains for medical devices Issues related to med tech reimbursement globally
Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs Issues related to digital health Issues related to smoke evacuation in the OR
Issues related to school safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2025 · second_quarter · Q2
Issues related to global supply chains for medical devices
Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs Issues related to digital health Issues related to smoke evacuation in the OR
Issues related to school safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
STRYKER CORPORATION via STRYKER CORPORATION
2025 · first_quarter · Q1
Issues related to global supply chains for medical devices
Issues related to global supply chains Issues related to reprocessing Issues related to PPE Issues related to prevention of hospital-acquired pneumonia Issues related to rural EMS programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2024 · fourth_quarter · Q4
Issues related to global supply chains for medical devices
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to reprocessing Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs Issues related to PPE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2024 · third_quarter · Q3
Issues related to global supply chains for medical devices
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to reprocessing Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs Issues related to PPE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2024 · second_quarter · Q2
Issues related to global supply chains for medical devices
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs Issues related to PPE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2024 · first_quarter · Q1
Issues related to global supply chains for medical devices
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs Issues related to PPE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2023 · fourth_quarter · Q4
Issues related to global supply chains for medical devices
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs Issues related to PPE
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2023 · third_quarter · Q3
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs Issues related to PPE
Issues related to global supply chains for medical devices Country specific trade and market access issues in Japan and China
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2023 · second_quarter · Q2
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs
Issues related to global supply chains for medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2023 · first_quarter · Q1
Issues related to global supply chains for medical devices
Issues related to global supply chains for medical devices Issues related to disparities in care Issues related to prevention of hospital acquired pneumonia Issues related to access to AEDs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2022 · fourth_quarter · Q4
Issues related to the FDA including Cures 2.0 legislation Issues related to the global supply chains for medical devices Issues related to the remanufacturing of medical devices Issues related to disparities in care Issues related to Hospital Acquired Pneumonia
Issues related to a global supply chain for medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2022 · third_quarter · Q3
Issues related to the FDA including Cures 2.0 legislation, and the Medical Device User Fee re-authorization Issues related to the global supply chains for medical devices Issues related to the remanufacturing of medical devices Issues related to disparities in care Issues related to Hospital Acquired Pneumonia
Issues related to a global supply chain for medical devices Country specific trade and market access issues in Japan, China and India
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2022 · second_quarter · Q2
Issues related to the FDA including Cures 2.0 legislation, and the Medical Device User Fee re-authorization Issues related to the global supply chains for medical devices Issues related to the remanufacturing of medical devices Issues related to disparities in care Issues related to Hospital Acquired Pneumonia
Issues related to a global supply chain for medical devices Country specific trade and market access issues in Japan, China and India
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2022 · first_quarter · Q1
Issues related to a global supply chain for medical devices Country specific trade and market access issues in Japan, China and India
Issues related to the FDA including Cures 2.0 legislation, and the Medical Device User Fee re-authorization Issues related to the global supply chains for medical devices Issues related to the remanufacturing of medical devices Issues related to the sterilization of medical devices Issues related to disparities in care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2021 · fourth_quarter · Q4
Issues related to the FDA including Cures 2.0 legislation, the Medical Device User Fee re-authorization Issues related to the global supply chains for medical devices Issues related to the servicing of medical devices Issues related to the sterilization of medical devices Issues related to disparities in care
Issues related to a global supply chain for medical devices Country specific trade and market access issues in Japan, China and India
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2021 · third_quarter · Q3
21st Century Cures 2.0 Legislation to decrease health disparities Regulation of medical device servicing
Global supply chain Global trade Market access in China
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS)
STRYKER CORPORATION via STRYKER CORPORATION
2021 · second_quarter · Q2
21st Century Cures 2.0 Legislation to decrease health disparities Regulation of medical device servicing
Global supply chain Global trade Tariff classifications Market access in China
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2021 · first_quarter · Q1
FDA COVID response Legislation to decrease health disparities
Medicare COVID relief Medicare Coverage of Innovative Technologies policy Medicare outpatient hospital payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2020 · fourth_quarter · Q4
Medicare COVID relief
FDA COVID response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2020 · third_quarter · Q3
Medicare bundled payment policy Medicare COVID relief Hospital Acquired Conditions
FDA COVID response
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2020 · second_quarter · Q2
Pricing policies in China Global Supply Chain and Trade
FDA Device reporting legislation and COVID response
Medicare outpatient payment policy Medicare COVID relief for hospitals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2020 · first_quarter · Q1
Pricing policies in China Global Supply Chain and Trade
Medicare Bundled Payments for Care Improvement Advanced Medicare outpatient payment policy Medicare Local Coverage Determination Policy Medicare COVID relief for hospitals
FDA Device reporting legislation and COVID support
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2019 · fourth_quarter · Q4
Repeal of the medical device tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2019 · third_quarter · Q3
Repeal of the medical device tax
Cybersecurity legislation under development
Japan national health insurance reimbursement revision for 2020 Pricing policies in India
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2019 · second_quarter · Q2
Repeal of the medical device tax
Cybersecurity legislation under development
US Japan trade negotiations China trade and tariffs Pricing policies in India
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2019 · first_quarter · Q1
Repeal of the medical device tax
Cybersecurity legislation under development
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2018 · fourth_quarter · Q4
Legislation to repeal the Medical Device Excise Tax
Medical Device Servicing Cybersecurity legislation under development
China trade tariffs US Japan trade negotiations
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2018 · third_quarter · Q3
China trade tariffs
Legislation to repeal the Medical Device Excise Tax
Medical Device Servicing Cybersecurity legislation under development Opioid Policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2018 · second_quarter · Q2
China trade tariffs India trade policies
Legislation to repeal the Medical Device Excise Tax
Medical Device Servicing Cybersecurity legislation under development Opioid Policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2018 · first_quarter · Q1
Medical Device Servicing Cybersecurity legislation under development Opioid Policy Medical Device Reprocessing
Legislation to repeal the Medical Device Excise Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2017 · fourth_quarter · Q4
Medicare codes related to neurovascular procedures Revisions to the Medicare Claims Form Bundled payment programs
Legislation to repeal the Medical Device Excise Tax Tax reform legislation
Seeking Congressional and Administration support related to new medical device price controls in India
STRYKER CORPORATION via STRYKER CORPORATION
2017 · third_quarter · Q3
Seeking Congressional and Administration support related to new medical device price controls in India
Legislation to repeal the Medical Device Excise Tax Tax reform legislation under development
Re-authorization of the FDA Medical Device User Fee Agreement Physician Owned Distributorship Models cybersecurity legislation under development
STRYKER CORPORATION via STRYKER CORPORATION
2017 · second_quarter · Q2
Telehealth Proposals Revisions to the Medicare Claims Form Bundled payment programs
Re-authorization of the FDA Medical Device User Fee Agreement Physician Owned Distributorship Models
Seeking Congressional and Administration support related to new medical device price controls in India
STRYKER CORPORATION via STRYKER CORPORATION
2017 · first_quarter · Q1
Seeking Congressional support related to new medical device price controls in India
Legislation to repeal the Medical Device Excise Tax
Telehealth Proposals CMS/FDA Breakthrough Pathway legislation - funding provisions Revisions to the Medicare Claims Form Finance Committee work on Stark and Anti-kick Back legislation and risk sharing models
STRYKER CORPORATION via STRYKER CORPORATION
2016 · fourth_quarter · Q4
21st Century Cures Legislation Physician Owned Distributorship model Unique Device Identification implementation and use
Telehealth proposals Finance Committee work on Stark and Anti-kick back law Medicare procedure codes Revisions to Medicare Claims Forms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
STRYKER CORPORATION via STRYKER CORPORATION
2016 · third_quarter · Q3
Trans-Pacific Partnership agreement
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals Finance Committee work on Stark and Anti-kick back law Medicare procedure codes
Department of Veterans Affairs Procurement Policy
STRYKER CORPORATION via STRYKER CORPORATION
2016 · second_quarter · Q2
Import tariff on implant screws - consideration by WTO and US CBP Trade with India
Senate Healthier Americans proposal and FDA reform legislation Physician Owned Distributorship model Unique Device Identification implementation
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals Ways & Means Committee hospital payment reform proposals Finance Committee work on Stark and Anti-kick back law
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2016 · first_quarter · Q1
Senate Healthier Americans proposal and FDA reform legislation Physician Owned Distributorship model
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals Ways & Means Committee hospital payment reform proposals Work on potential new ICD-10 codes
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2015 · fourth_quarter · Q4
Energy & Commerce Committee 21st Century Cures Initiative Senate Healthier Americans proposal Physician Owned Distributorship models, Senate Finance hearing
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals Ways & Means Committee hospital payment reform proposals
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2015 · third_quarter · Q3
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals
Energy & Commerce Committee 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Customs & Border Protection
STRYKER CORPORATION via STRYKER CORPORATION
2015 · second_quarter · Q2
Energy & Commerce Committee 21st Century Cures Initiative
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals
H.R. 523 and S. 232, legislation to repeal the Medical Device Excise Tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2015 · first_quarter · Q1
Repeal of the Medical Device Excise Tax
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Telehealth proposals
The Software Act - legislation related to the FDA regulation of health information technology, mobile medical apps and software Energy & Commerce Committee 21st Century Cures Initiative
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
STRYKER CORPORATION via STRYKER CORPORATION
2014 · fourth_quarter · Q4
S. 232 The Medical Device access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
Implementation of Public Law 111-148, the Patient Protetion and Affordable Care Act, particularly accountable care organizations and bundled payment models. Meeting with Medicare to discuss reassignment of neurovascular procedures to different DRGs.
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act H.R. 3303, the Software Act - FDA regulation of health information technology, mobile medical applications and software Telehealth legislation Energy & Commerce Committee 21st Century Cures Initiative
STRYKER CORPORATION via STRYKER CORPORATION
2014 · third_quarter · Q3
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations, bundled payment models, and the Physician Payment Sunshine Act.
S. 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act, HR 3303, the Software Act - FDA regulation of health information technology and mobile medical applications
STRYKER CORPORATION via STRYKER CORPORATION
2014 · second_quarter · Q2
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Discussed appropriate Medicare inpatient hopspital MS-DRG assignments
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act, in particular the custom device provision H.R. 3303, the Software Act - FDA regulation of health information technology and mobile medical applications
S 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - to repeal the 2.3% excise tax on medical devices Legislation to make the R&D tax credit permanent
STRYKER CORPORATION via STRYKER CORPORATION
2014 · first_quarter · Q1
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act H.R. 3303, the Software Act - FDA regulation of health information technology and mobile medical applications
S. 232, the Medical Device Access and Innovation Protection Act and H.R. 523, the Protect Medical Innovation Act - repeal the 2.3% excise tax on medical devices
STRYKER CORPORATION via STRYKER CORPORATION
2013 · fourth_quarter · Q4
Implementation of Public Law 111-148: The Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models Medicare Reimbursement for joint replacement procedures
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act
Funding for the FDA Center for Devices and Radiological Health
STRYKER CORPORATION via STRYKER CORPORATION
2013 · third_quarter · Q3
Implementation of Public Law 111-148: The Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models
Funding for the FDA Center for Devices and Radiological Health
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act
STRYKER CORPORATION via STRYKER CORPORATION
2013 · second_quarter · Q2
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act
Implementation of Public Law 111-148: The Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models
STRYKER CORPORATION via STRYKER CORPORATION
2013 · first_quarter · Q1
H.R. 933, Consolidated and Further Continuing Appropriations Act of 2013, particularly appropriations for the FDA Center for Devices and Radiological Health
Implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models
STRYKER CORPORATION via STRYKER CORPORATION
2012 · fourth_quarter · Q4
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2012 · third_quarter · Q3
Legislation to repeal the Medical Device Excise Tax, S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
FDA's Medical Device User Fee Program
Implementation of Public Law 111-148, the Patient Protection and Affordable care Act, particularly accountable care organizations and bundled payment models
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2012 · second_quarter · Q2
Reauthorization of the FDA Medical Device User Fee Program and associated FDA legislation
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, H.R. 488
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Accountable Care Organizations and new payment models
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2012 · first_quarter · Q1
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Accountable Care Organizations, and new payment systems
Reauthorization of the FDA Medical Device User Free program and associated FDA legislation such as H.R. 3209, H.R. 3203, H.R. 3230, H.R. 3205, H.R. 3208, H.R. 3206, H.R. 3214, H.R. 3204 and S. 1700, S. 1865 and S. 1995. Discussion drafts on medical device user fee legislation from the House Energy & Commerce Committee and the Senate Health, Education, Labor and Pensions Committee
Legislation to repeal the Medical Device Excise Tax: S. 17, S. 262, H.R. 436, H.R. 734, and H.R. 488
STRYKER CORPORATION via STRYKER CORPORATION
2011 · fourth_quarter · Q4
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Accountable Care Organizations, new payment systems, the Independent Payment Advisory Board, the Sunshine Act, and the Medical Device Excise Tax The Medical Device User Fee Program Reform of the FDA 510(k) regulatory process
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2011 · third_quarter · Q3
Reform of the FDA regulatory review and approval processes Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Accountable Care Organizations, new payment systems, the Independent Payment Advisory Board, the Sunshine Act, and the medical device excise tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2011 · second_quarter · Q2
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Accountable Care Organizations, the Independent Payment Advisory Board, the Sunshine Act, and the medical device tax. Reform of the FDA 510(k) regulatory pathway Reauthorization of the Medical Device User Fee Program
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2011 · first_quarter · Q1
Reform of the FDA 510(k) regulatory pathway Reauthorization of the FDA Medical Device User Fee program
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act, particularly Medicare payment reforms, the Medical Device Tax, and physician payment disclosure
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2010 · fourth_quarter · Q4
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Reform of the FDA 510(k) regulatory pathway
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2010 · third_quarter · Q3
Implementation of Public Law 111-148, the Patient Protection and Affordable Care Act Reform of the FDA 510(k) regulatory pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2010 · second_quarter · Q2
Implementation of H.R. 3590, the Patient Protection and Affordable Care Act, to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes Reform of the FDA 510(k) regulatory pathway
Filing targets: HOUSE OF REPRESENTATIVES
STRYKER CORPORATION via STRYKER CORPORATION
2010 · first_quarter · Q1
Medical device tax included in House and Senate health reform bills
U.S. Senate and U.S. House of Representatives health care reform bills - specifically physician payment disclosure, comparative effectiveness research, bundled payments, medical device registry and medical device tax proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2009 · fourth_quarter · Q4
Medical device tax included in House and Senate health reform bills
U.S. Senate and U.S. House of Representatives health care reform bills - specifically physician payment disclosure, comparative effectiveness research, bundled payments, medical device registry and medical device tax proposals Reform of the FDA 510(k) regulatory pathway
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
STRYKER CORPORATION via STRYKER CORPORATION
2009 · third_quarter · Q3
S. 301, Physician Payments Sunshine Act, legislation to require the disclosure of relationships between physicians and drug and device manufacturers S. 1679, the Affordable Health Choices Act, HR 3200, America's Affordable Health Choices Act of 2009, and America's Healthy Future Act - specifically comparative effectiveness research, physician disclosure, bundling, device registry and device tax proposals
H.R. 1346, The Medical Device Safety Act of 2009 Reform of the 510(k) regulatory pathway
Medical Device Tax included in America's Healthy Future Act (Senate Finance Commitee legislation)
STRYKER CORPORATION via STRYKER CORPORATION
2009 · second_quarter · Q2
HR 1346/S540, The Medical Device Safety Act of 2009 HR 2813, The National Knee and Hip Replacement Registry Act of 2009 Reform of the 510(k) regulatory pathway Statement for the record on arthritis and related procedures
S. 301, Physician Payments Sunshine Act, legislation to require the disclosure of relationships between physicians and drug and device manufacturers Comparative Effectiveness Research to compare the clinical effectiveness of medical treatments New Technology Add-on Payments related to Medicare bundling proposals included in healthcare reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2009 · first_quarter · Q1
HR 1346/S 540, The Medical Device Safety Act of 2009 Comparative effectiveness research to compare the clinical effectiveness of medical treatments
Filing targets: SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2008 · fourth_quarter · Q4
Implementation of P.L. 109-461 Related to Department of Veterans Affairs Procurement Procedures
H.R. 6381, The Medical Device Safety Act of 2008 HCR-related legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2008 · third_quarter · Q3
Medicare Reimbursement issues Revisions to Physician Self-Referral Law
Implementation of P.L. 109-461 Related to Department of Veterans Affairs Procurement Procedures
H.R. 6381, The Medical Device Safety Act of 2008
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2008 · second_quarter · Q2
H.R. 6381, The Medical Device Safety Act of 2008
Implementation of P.L. 109-461 Related to Department of Veterans Affairs Procurement Procedures
S. 2029, the Physician Payment Sunshine Act Revisions to Physician Self-Referral Law Medicare Reimbursement Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
STRYKER CORPORATION via STRYKER CORPORATION
2008 · first_quarter · Q1
Medical Device Amendments of 1976 - preemption language
S. 2221, the Medical Device Price Transparency Act S. 2029, the Physician Payment Sunshine Act Revisions to Physician Self-Referral Law
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
STRYKER CORPORATION via STRYKER CORPORATION
2007 · year_end · YY
S. 2499, the Medicare, Medicaid and SCHIP Extension Act of 2007 Medicare reimbursement
S. 1082/H.R. 2900 Reuthorization of the Medical Device User Fee and Modernization Act H.R. 1494/S.830 The Pediatric Medical Device Safety and Improvement Act
Medical Device regulatory and reimbursement policy issues in Korea, China and Japan
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
STRYKER CORPORATION via STRYKER CORPORATION
2007 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medical Device Servicing Physician Owned Distributorship Models Cybersecurity legislation under development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Telehealth Proposals Revisions to the Medicare Claims Form Bundled payment programs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Legislation to repeal the Medical Device Excise Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Implementation of 21st Century Cures legislation Senate HELP Committee discussion draft to extend and revise the FDA Medical Device User Fee Program Physician Owned Distributorship Models Federal Device Distribution Licensing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Senate Healthier Americans proposal and FDA reform legislation Physician Owned Distributorship model Unique Device Identification implementation and use
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 232, Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Funding for the FDA Center for Devices and Radiological Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE